epiberberine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M; Gu, Y; Huang, H; Sun, Y; Wang, X; Wu, T; Yan, J; Yin, W; Zhang, X; Zhang, Z; Zhao, D | 1 |
| Chen, X; Hou, Y; Kong, Q; Liu, X; Lu, JJ; Zhang, Q; Zhang, Y; Zhou, GJ | 1 |
2 other study(ies) available for epiberberine and Experimental Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzofurans; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2021 |
Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.
Topics: Animals; Antineoplastic Agents; Berberine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Smad3 Protein; Transforming Growth Factor beta1 | 2020 |